AIM ImmunoTech

YTD

ALL

Why Robinhood?

You can watch AIM ImmunoTech and buy or sell other stocks, ETFs, and their options commission-free!

About AIMI

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen.

CEO

Thomas Kenwood Equels

CEOThomas Kenwood Equels

Employees

Employees23

Headquarters

Ocala, Florida

HeadquartersOcala, Florida

Founded

1966

Founded1966

Employees

Employees23

AIMI Key Statistics

Market cap

6.69M

Market cap6.69M

Price-Earnings ratio

-0.34

Price-Earnings ratio-0.34

Dividend yield

—

Dividend yield—

Average volume

92.50K

Average volume92.50K

High today

$0.09

High today$0.09

Low today

$0.0784

Low today$0.0784

Open price

$0.079

Open price$0.079

Volume

29.99K

Volume29.99K

52 Week high

$0.469

52 Week high$0.469

52 Week low

$0.0251

52 Week low$0.0251

People also own

Based on the portfolios of people who own AIMI. This list is generated using Robinhood data, and it’s not a recommendation.